Healthcare -
Medical - Diagnostics & Research - NYSE - US
$ 164.695
-0.372 %
$ 8.42 B
Market Cap
823.47
P/E
CRL - COST OF REVENUE
Cost of Revenue CRL - Charles River Laboratories International, Inc.
2.72 B
LAST VALUE
3.99%
2 YEAR CAGR
10.33%
5 YEAR CAGR
12.66%
10 YEAR CAGR